TCR² Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.

Biotechnology

Education

TCR² Therapeutics

Peter Olagunju

Viera Muzithras

Robert Tighe

Richard Roomberg

Angela Justice

Alfonso Quintás Cardama

Eric Sullivan

Chirag Khatiwala

Rosemary Harrison

The board of directors at TCR² Therapeutics is made up of various members with experience in different industries and levels of education. Some members have experience working with AlloVir, 4D Molecular Therapeutics, Principia Biopharma, and Gamida Cell Ltd. while others have degrees in marketing and business from the University of Cincinnati and Murray State University.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at TCR² Therapeutics

Leadership Team

CEO and Executive Team